Zhaolei Zeng
Overview
Explore the profile of Zhaolei Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang H, Luo X, Yang W, Wu Z, Zhao Z, Pei X, et al.
Nat Commun
. 2024 Nov;
15(1):9559.
PMID: 39500904
RNA methylation is an important regulatory process to determine immune cell function but how it affects the anti-tumor activity of CD8 T cells is not fully understood. Here we show...
2.
Yong J, Cai S, Zeng Z
Front Immunol
. 2023 Dec;
14:1269896.
PMID: 38116009
Nicotinamide adenine dinucleotide (NAD) is indispensable for various oxidation-reduction reactions in mammalian cells, particularly during energy production. Malignant cells increase the expression levels of NAD biosynthesis enzymes for rapid proliferation...
3.
Deng J, Yang Y, Zeng Z, Xiao X, Li J, Luan T
Anal Chem
. 2021 Sep;
93(38):13089-13098.
PMID: 34523336
Discovering cancer biomarkers is of significance for clinical medicine and disease diagnosis. In this article, we develop an in-capillary extraction nanoelectrospray ionization mass spectrometry (ICE-nanoESI-MS) method to rapidly and investigate...
4.
Tang M, Zeng L, Zeng Z, Liu J, Yuan J, Wu D, et al.
J Proteomics
. 2021 Apr;
243:104246.
PMID: 33915303
Colorectal cancer (CRC) is a malignant tumour with high morbidity and mortality worldwide. Efficient screening strategies for CRC and pre-cancerous lesions can promote early medical intervention and treatment, thereby reducing...
5.
Luo H, Zhao Q, Wei W, Zheng L, Yi S, Li G, et al.
Sci Transl Med
. 2020 Jan;
12(524).
PMID: 31894106
Circulating tumor DNA (ctDNA) has emerged as a useful diagnostic and prognostic biomarker in many cancers. Here, we conducted a study to investigate the potential use of ctDNA methylation markers...
6.
Zhang L, Zeng J, Zeng Z, Wang F, Wang D, Chen C, et al.
Tumour Biol
. 2016 Mar;
37(8):11443-56.
PMID: 27006309
The identification of new, effective drugs is a pressing need in colorectal cancer (CRC) rescue therapy. Data examining O (6)-methylguanine-DNA-methyl transferase (MGMT) and its predictive role in temozolomide (TMZ) treatment...
7.
Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, et al.
Clin Cancer Res
. 2012 Jun;
18(15):4059-69.
PMID: 22675169
Purpose: Golgi phosphoprotein 3 (GOLPH3) has been reported to be involved in various biologic processes. The clinical significance and biologic role of GOLPH3 in breast cancer, however, remains unknown. Experimental...
8.
Tang Z, Yuan S, Hu Y, Zhang H, Wu W, Zeng Z, et al.
J Bioenerg Biomembr
. 2012 Feb;
44(1):117-25.
PMID: 22350014
It has long been observed that many cancer cells exhibit increased aerobic glycolysis and rely more on this pathway to generate ATP and metabolic intermediates for cell proliferation. Glyceraldehyde-3-phosphate dehydrogenase...
9.
Wu M, Zeng J, Chen Y, Zeng Z, Zhang J, Cai Y, et al.
Oncol Rep
. 2012 Feb;
27(5):1417-28.
PMID: 22344888
Circadian rhythm has been linked to cancer genesis and development, but the detailed mechanism by which circadian disruption accelerates tumor growth remains unclear. The purpose of this study was to...
10.
Jiang G, Li J, Zeng Z, Xian L
Cancer Biol Ther
. 2006 Apr;
5(4):435-40.
PMID: 16575205
Despite advances in surgery, radiotherapy, and chemotherapy, the long-term survival rates with oral squamous cell carcinoma (OSCC) have not significantly improved. Gene therapy for OSCC is currently under investigation in...